MAIDA, Ivana
 Distribuzione geografica
Continente #
NA - Nord America 10.611
EU - Europa 5.914
AS - Asia 5.405
SA - Sud America 2.926
Continente sconosciuto - Info sul continente non disponibili 353
AF - Africa 218
OC - Oceania 20
Totale 25.447
Nazione #
US - Stati Uniti d'America 10.333
IT - Italia 2.624
BR - Brasile 2.578
SG - Singapore 2.166
CN - Cina 1.598
UA - Ucraina 945
FR - Francia 624
HK - Hong Kong 519
DE - Germania 481
VN - Vietnam 398
SE - Svezia 271
FI - Finlandia 194
GB - Regno Unito 156
AR - Argentina 121
NL - Olanda 118
IE - Irlanda 105
CA - Canada 98
BD - Bangladesh 90
RU - Federazione Russa 78
TR - Turchia 78
IN - India 72
MX - Messico 66
IQ - Iraq 64
ZA - Sudafrica 61
EC - Ecuador 60
ES - Italia 50
PL - Polonia 46
PK - Pakistan 45
CZ - Repubblica Ceca 42
JP - Giappone 42
MA - Marocco 40
KR - Corea 37
UZ - Uzbekistan 37
VE - Venezuela 33
CO - Colombia 32
ID - Indonesia 30
PY - Paraguay 30
BE - Belgio 29
AZ - Azerbaigian 27
AT - Austria 25
AE - Emirati Arabi Uniti 24
KE - Kenya 23
TN - Tunisia 23
CH - Svizzera 22
CL - Cile 22
AU - Australia 20
PE - Perù 20
UY - Uruguay 20
IR - Iran 19
LT - Lituania 19
CR - Costa Rica 18
DZ - Algeria 18
JM - Giamaica 18
KZ - Kazakistan 18
EG - Egitto 17
NI - Nicaragua 14
IL - Israele 13
JO - Giordania 13
NP - Nepal 13
LB - Libano 12
PA - Panama 12
SA - Arabia Saudita 12
EU - Europa 11
AL - Albania 10
GT - Guatemala 10
HN - Honduras 10
PH - Filippine 10
PS - Palestinian Territory 10
RS - Serbia 10
DO - Repubblica Dominicana 9
SN - Senegal 9
BO - Bolivia 8
HU - Ungheria 8
GA - Gabon 7
OM - Oman 7
RO - Romania 7
BG - Bulgaria 6
BH - Bahrain 6
BY - Bielorussia 6
GE - Georgia 6
KG - Kirghizistan 6
KW - Kuwait 6
NG - Nigeria 6
QA - Qatar 6
SV - El Salvador 5
BA - Bosnia-Erzegovina 4
ET - Etiopia 4
GR - Grecia 4
MD - Moldavia 4
MK - Macedonia 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AO - Angola 3
CW - ???statistics.table.value.countryCode.CW??? 3
GP - Guadalupe 3
MY - Malesia 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
Totale 25.065
Città #
Dallas 2.622
Singapore 1.167
San Jose 954
Chandler 913
Ashburn 647
Jacksonville 562
Hong Kong 511
Council Bluffs 449
Beijing 337
Princeton 333
Santa Clara 293
Milan 281
Nanjing 254
Columbus 219
Rome 204
Dearborn 187
São Paulo 180
New York 169
Lauterbourg 166
Ho Chi Minh City 154
Wilmington 126
Los Angeles 117
Shanghai 111
Boardman 108
Nanchang 103
Sassari 101
Dublin 99
Ann Arbor 97
Hanoi 92
Rio de Janeiro 89
Naples 77
Shenyang 75
Belo Horizonte 67
Tianjin 64
Munich 59
Florence 57
Woodbridge 50
Hebei 48
Brasília 47
Changsha 46
Turin 45
Helsinki 44
Porto Alegre 41
Tokyo 40
Atlanta 38
Orem 38
Andover 37
Brno 37
Jiaxing 37
San Francisco 37
Nuremberg 36
Palermo 36
Toronto 36
Buffalo 35
Campinas 35
Tashkent 35
Bari 34
Jinan 34
Miano 34
Phoenix 34
Bologna 33
Chicago 32
Seoul 32
Hangzhou 31
Brooklyn 30
Curitiba 30
Frankfurt am Main 30
Goiânia 30
Warsaw 30
Guarulhos 29
Ningbo 28
Brussels 27
Johannesburg 26
Baghdad 25
Montreal 25
Norwalk 25
Ribeirão Preto 25
Zhengzhou 25
Baku 24
Dhaka 24
Denver 22
Kunming 22
Salvador 22
Sorocaba 22
Fortaleza 20
Houston 20
Montevideo 20
Nairobi 20
Turku 20
Genoa 19
Verona 19
Catania 18
Guangzhou 18
Haiphong 18
London 18
Asunción 17
Buenos Aires 17
Campo Grande 17
Juiz de Fora 17
São José dos Campos 17
Totale 13.922
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 2.156
Accertamento diagnostico di meningoencefalite da Listeria monocytogenes mediante PCR in soggetti immunocompetenti 298
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 294
Analisi dell'attività dei C.I.O. in ambito regionale e proposta di un modello organizzativo - funzionale 244
Strategie di sorveglianza attiva e networking per il controllo delle infezioni da L. monocytogenes 242
Analisi del case-mix ospedaliero. Il controllo dei ricoveri outlier 237
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 225
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 218
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 208
Approccio molecolare nello studio di un episodio infettivo ospedaliero da Pseudomonas aeruginosa 197
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 197
Andamento della parotite epidemica nell’Azienda USL n.1 di Sassari e considerazioni sulle strategie vaccinali 195
Aspetti epidemiologici sulla colonizzazione da Streptococcus agalactiae nelle donne in gravidanza. 193
Aspetti epidemiologici di infezioni gastroenteriche in paesi in via di sviluppo 192
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 191
Antibiotic resistant H-pylori are extremely common in Sardinia. 191
alpha-and gamma-tocophetol modulate the apoptotic signaling induced by oxidized low-density lipoprotein in human coronaric smooth muscle cells 189
Approccio molecolare nella diagnosi della tubercolosi umana 182
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 181
Associazione sierologia tra HIV e Trichomonas vaginalis nella popolazione femminile del Nord-Sardegna. 179
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 178
Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C 170
Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains 167
Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. 166
QuantiFERON TB Gold: a new method for latent tuberculosis infection 166
Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir 157
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 157
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 156
Comparison of 2D Shear Wave Elastography and Transient Elastography in Non-Invasive Evaluation of Liver Fibrosis in Hepatitis C Virus-Related Chronic Liver Disease 153
Clonal relationships among Salmonella enteritidis phage type 3 outbreak isolates traced by DNA fingerprinting 152
Andamento delle infezioni nosocomiali nel complesso chirurgico Università- Azienda USL n. 1- Sassari. 152
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 151
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 151
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 150
Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: Role of neutropenia and of interferon pegylation 150
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 149
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 148
Utilizzo della metodologia bayesiana per lo studio della variazione geografica del rischio in epidemiologia. 147
PREVENTION OF TRAVEL ASSOCIATED INFECTION DUE TO LEGIONELLA: MICROBIOLOGIC ANALYSIS IN LINERS AND CRUISE SHIPS 147
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 147
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 147
Valutazione della qualità delle schede di dimissione ospedaliera 146
Pulmonary Involvement in Recurrent Respiratory Papillomatosis: A Systematic Review 142
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 141
Neurocognitive performance and cardiovascular risk in a cohort of HIV-infected patients 140
Rapid detection and identification of Mycobacterium tuberculosis by Real Time PCR and Bactec 960 MIGT 140
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 138
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome 138
Inquinamento ambientale nelle sale operatorie. Nota II: condizioni microclimatiche e microbiologiche 138
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 136
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 135
Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus 135
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 135
Listeria monocytogenes meningoencephalitis: molecular methods for diagnosis and for monitoring the response to chemotherapy 134
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 134
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 134
Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes 134
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir. 134
Characterization of resistance profiles in HCV 2-3-4 DAA-naive and DAA-experienced infected patients in Italy 132
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 132
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study. 131
Hepatitis C virus-RNAclearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin 131
Joint replacement for avascular necrosis in people living with HIV 130
Genetic determinants in critical domains of NS5A are associated with genotype 1b HCV-induced hepatocellular carcinoma 128
HIV related aneurisms 128
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 127
Epidemiology of Salmonellosis in Sardinia, Italy: 1995-2001 127
Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience 127
OPERA: use of pegylated interferon plus ribavirin for treating hepatitis C/HIV co-infection in interferon-naive patients. 127
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 126
Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients 126
Monitoraggio di metalli pesanti nelle acque costiere della Sardegna settentrionale mediante utilizzo di indicatori biologici 126
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes 126
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 122
Epidemiologia e prevenzione delle infezioni da Micobatteri su base molecolare 122
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 121
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies 121
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 121
Database per il monitoraggio del rischio professionale negli operatori sanitari 120
Failure of Hepatitis C Therapy in HIV-Coinfected Drug Users Is Not Due to a Shift in Hepatitis C Virus Genotype 120
Serum homocysteine levels are increased in women with gestational diabetes mellitus 120
Modulation by α- and γ-tochopherol and oxidized low density lipoprotein in human coronaric smooth muscle cells 120
Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients 119
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. 119
Severe liver disease associated with prolonged exposure to antiretroviral drugs 118
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 117
The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women 117
Surveillance of Poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results 117
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies 116
The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients 116
Very late HCV relapse following triple therapy for hepatitis C. 115
Correlates of HIV, HBV, and HCV infection in a prison inmate population: Results from a multicentre study in Italy 115
Characteristics and Prospects for Hepatitis C Therapy of an HIV-HCV Coinfected Population Followed at a Reference HIV Center 114
Triple-nucleoside regimens versus efavirenz 114
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation 114
Specific Genetic Determinants in NS5A and Core Regions Correlate with Genotype 1b HCV-Induced Hepatocellular Carcinoma: Implications for Viral Markers of Disease Progression 114
Hepatitis C Viremia in HIV/HCV-Coinfected Patients: Lower Levels in Presence of Chronic Hepatitis B 113
Complications in treating chronic hepatitis B in patients with HIV 113
Evalutaion and comparison of molecular techniques for epidemiological typing of M. tuberculosis 113
Simplification From Protease Inhibitors to Once- or Twice-Daily Raltegravir: The ODIS Trial 112
Totale 16.891
Categoria #
all - tutte 98.743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.743


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022762 0 0 0 46 18 19 45 67 77 32 110 348
2022/20231.962 199 101 39 314 190 334 21 222 331 25 108 78
2023/2024930 105 62 32 41 193 96 27 52 16 57 97 152
2024/20255.792 113 161 376 136 197 193 360 1.074 1.964 763 314 141
2025/20268.413 345 1.982 1.231 1.222 735 451 1.168 236 332 387 194 130
2026/20272.798 306 647 829 1.016 0 0 0 0 0 0 0 0
Totale 25.447